Le Lézard
Classified in: Business
Subject: ATY

PATTERSON COMPANIES LEAD PLAINTIFF DEADLINE ALERT: Faruqi & Faruqi, LLP Encourages Investors Who Suffered Losses Exceeding $50,000 In Patterson Companies, Inc. To Contact The Firm


NEW YORK, May 25, 2018 /PRNewswire/ -- Faruqi & Faruqi, LLP, a leading national securities law firm, reminds investors in Patterson Companies, Inc. ("Patterson" or the "Company") (NASDAQ: PDCO) of the May 29, 2018 deadline to seek the role of lead plaintiff in a federal securities class action that has been filed against the Company.

Faruqi & Faruqi, LLP. (PRNewsfoto/Faruqi & Faruqi, LLP)

If you invested in Patterson stock or options between June 26, 2015 and February 28, 2018 and would like to discuss your legal rights, click here: www.faruqilaw.com/PDCO. There is no cost or obligation to you.

You can also contact us by calling Richard Gonnello toll free at 877-247-4292 or at 212-983-9330 or by sending an e-mail to [email protected].   

CONTACT:
FARUQI & FARUQI, LLP
685 Third Avenue, 26th Floor
New York, NY 10017
Attn:  Richard Gonnello, Esq.
[email protected]
Telephone: (877) 247-4292 or (212) 983-9330

The lawsuit has been filed in the U.S. District Court for the District of Minnesota on behalf of all those who purchased Patterson securities between July 31, 2014 and June 15, 2015 (the "Class Period").  The case, Plymouth County Retirement System v. Patterson Companies, Inc. et al No. 18-cv-00871 was filed on March 28, 2018 and has been assigned to Judge Davis.

The lawsuit focuses on whether the Company and its executives violated federal securities laws by making false and/or misleading statements and/or failed to disclose that: (1) were engaged in a fraudulent and illegal price-fixing conspiracy; (2) the Company's revenue and earnings were fraudulently inflated by the illegal scheme; (3) the scheme was aimed at prohibiting sales to and price negotiations by group purchasing organizations that represented small and independent dental practices; (4) as a result of the foregoing, statements about Patterson's business, operations, and prospects were materially false and/or misleading and/or lacked a reasonable basis.

Specifically, on March 1, 2018 press release announced the immediate resignation of Gugino from her role as CFO. The Company appointed Dennis Goedken, Patterson's corporate controller, to serve as interim CFO, while the Company searches for a permanent replacement. Following her resignation, Gugino is serving as a special advisor to the Company until July 31, 2018.

The court-appointed lead plaintiff is the investor with the largest financial interest in the relief sought by the class who is adequate and typical of class members who directs and oversees the litigation on behalf of the putative class. Any member of the putative class may move the Court to serve as lead plaintiff through counsel of their choice, or may choose to do nothing and remain an absent class member. Your ability to share in any recovery is not affected by the decision to serve as a lead plaintiff or not. 

Faruqi & Faruqi, LLP also encourages anyone with information regarding Patterson's conduct to contact the firm, including whistleblowers, former employees, shareholders and others.

Attorney Advertising. The law firm responsible for this advertisement is Faruqi & Faruqi, LLP (www.faruqilaw.com). Prior results do not guarantee or predict a similar outcome with respect to any future matter. We welcome the opportunity to discuss your particular case. All communications will be treated in a confidential manner.

SOURCE Faruqi & Faruqi, LLP


These press releases may also interest you

at 19:35
Regenx Tech Corp., (the "Company" or "Regenx") is providing this bi-weekly update on the status of the application to the Alberta Securities Commission for a management cease trade order, under National Policy 12-203 -?? Management Cease Trade...

at 19:14
Kadestone Capital Corp. ("Kadestone" or the "Company") , a vertically integrated property company today announced its financial results for the year ended December 31, 2023....

at 19:05
Appili Therapeutics Inc. (the "Company" or "Appili"), a biopharmaceutical company focused on drug development for infectious diseases and medical countermeasures, today announced it has secured additional bridge financing in the amount of C$300,000...

at 19:00
David J. Dykeman, co-chair of the Life Sciences & Medical...

at 18:54
Attorney Advertising-- Bronstein, Gewirtz & Grossman, LLC, a nationally recognized law firm, notifies investors that a class action lawsuit has been filed against Autodesk, Inc. ("Autodesk" or "the Company") and certain of its officers....

at 18:54
Cliffside Capital Ltd. ("Cliffside" or the "Company")  is pleased to announce financial results for the year ended December 31, 2023. The Company reported the following for 2023 compared with the prior year: Decline in gross finance receivables by...



News published on and distributed by: